Subscribe To

Price Alert Latest News Economic Calendar News

SNY / Sanofi (SNY) Q3 2023 Earnings Call Transcript

Sanofi (NASDAQ:SNY ) Q3 2023 Earnings Conference Call October 27, 2023 9:00 AM ET Company Participants Eva Schaefer-Jansen - Head of Investor Relations Paul Hudson - Chief Executive Officer Jean-Baptiste de Chatillon - Executive Vice President, Chief Financial Officer Houman Ashrafian - Global Head of R&D Julie Van Ongevalle - Executive Vice President, Consumer Healthcare Brian Ford - Head Specialty Care, North America and US Country Lead Thomas Triomphe - Executive Vice President, Vaccines Olivier Charmeil - Executive Vice President, General Medicines Conference Call Participants Luisa Hector - Berenberg Emily Field - Barclays Peter Welford - Jefferies Graham Parry - BofA Timothy Anderson - Wolfe Peter Verdult - Citi David Risinger - Leerink Florent Cespedes - Societe Generale Simon Baker - Redburn Seamus Fernandez - Guggenheim Richard Vosser - JPMorgan Eva Schaefer-Jansen [starts abruptly] You have joined the meeting as an attendee and will be muted throughout the meeting. This meeting is being recorded. Read More

Demo Live Account See Partner Details

Content Topics

Sanofi

SNY

2023

Earnings

Call

Transcript

Stock

Posted: Oct 27 2023, 14:26

Author Name: Seeking Alpha

SNY News

By The Motley Fool
November 3, 2023

This Stock Just Dropped By 15%: Is It a Buy?

Sanofi's third-quarter results weren't great, and the company announced a business separation. The biotech will lower its operating income margin targ

By Yahoo Finance
October 30, 2023

Sanofi stock recovers slightly after last week's plunge

Sanofi (SNY) shares are trending higher after plummeting last Friday, after the pharmaceutical company missed third-quarter earnings expectations, los

By Seeking Alpha
October 27, 2023

Sanofi (SNY) Q3 2023 Earnings Call Transcript

Sanofi (NASDAQ:SNY ) Q3 2023 Earnings Conference Call October 27, 2023 9:00 AM ET Company Participants Eva Schaefer-Jansen - Head of Investor Relation

By Zacks Investment Research
October 27, 2023

Sanofi (SNY) Beats on Q3 Earnings, to Spin-Off Consumer Unit

Sanofi (SNY) beats third-quarter estimates for earnings but misses the same for sales. It announces plans to separate its Consumer unit into a new pub

By InvestorPlace
October 27, 2023

SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff

Sanofi (NYSE: SNY ) stock fell about 15% overnight after it predicted slower profit growth next year. The French drug company also said it will follow

By CNBC Television
October 27, 2023

Sanofi CEO Paul Hudson on Q3 results: Increased R&D spending will impact 2024 profit

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, spin off of its consumer health care business, growth o

By Market Watch
October 27, 2023

Sanofi shares skid as French drugmaker outlines higher R&D expenses, taxes

Shares of French drugmaker Sanofi fell as much as 16% on Friday after after hiking its research-and-development expense guidance as well as its expect

By Reuters
October 27, 2023

Sanofi takes page from rivals' separation playbook

Sanofi on Friday mapped out a potential separate listing of its consumer healthcare business from the fourth quarter of next year, as it plans to shor

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.